On ECHEMI
Home > Drugs > Tianjin Pharmaceutical Heping (Tianjin) Pharmaceutical Co., Ltd.
Tianjin Pharmaceutical Heping (Tianjin) Pharmaceutical Co., Ltd.
  • Founded in:

    2010-11-12
  • Country:

    China China
  • Address:

    No. 221 Huanghai Road, Tianjin Development Zone
  • Tax NO.:

    91120116562691739J
  • Registered Funds:

    604.05 million yuan
  • Website:

  • Email:

Related Drugs
Flunarizine Hydrochloride Capsules
The main ingredient of this product is: Flunarizine hydrochloride. Its chemical name is: (E)-1-[bis(4-fluorophenyl)methyl]-4-2(2-propenyl-3-phenyl)-piperazine dihydrochloride. Molecular formula: C26H26F2N22HCl Molecular weight: 477.42
Name Description Content CAS NO. Registered Holders
Flunarizine dihydrochloride

This product is a calcium channel blocker, which can prevent cell damage caused by pathological intracellular calcium overload due to ischemia and other reasons; 1. Relieve vasospasm, and have a lasting inhibitory effect on persistent vasospasm caused by vasoconstrictor substances, especially on the basilar artery and internal carotid artery; 2. Vestibular inhibitory effect, which can increase the blood flow of cochlear arterioles and improve vestibular organ circulation; 3. Anti-epileptic effect, which can block the pathological calcium overload of nerve cells to prevent paroxysmal depolarization and cell discharge, thereby avoiding epileptic seizures; 4. Protect the myocardium and significantly reduce ischemic myocardial damage.

More

This product is a calcium channel blocker, which can prevent cell damage caused by pathological intracellular calcium overload due to ischemia and other reasons; 1. Relieve vasospasm, and have a lasting inhibitory effect on persistent vasospasm caused by vasoconstrictor substances, especially on the basilar artery and internal carotid artery; 2. Vestibular inhibitory effect, which can increase the blood flow of cochlear arterioles and improve vestibular organ circulation; 3. Anti-epileptic effect, which can block the pathological calcium overload of nerve cells to prevent paroxysmal depolarization and cell discharge, thereby avoiding epileptic seizures; 4. Protect the myocardium and significantly reduce ischemic myocardial damage.

30484-77-6 25
Triamcinolone acetonide acetate urea cream
This product is a compound preparation, containing 1 mg of triamcinolone acetonide acetate and 100 mg of urea per gram. The excipients are:
Name Description Content CAS NO. Registered Holders
Triamcinolone acetonide 21-acetate

Has anti-inflammatory, antipruritic and anti-allergic effects

More

Has anti-inflammatory, antipruritic and anti-allergic effects

1mg 3870-07-3 5
Urea

It has the function of dissolving and denaturing keratin and increasing the moisture of the stratum corneum, thus making the skin soft and preventing it from drying out.

More

It has the function of dissolving and denaturing keratin and increasing the moisture of the stratum corneum, thus making the skin soft and preventing it from drying out.

100mg 57-13-6 18
Amikacin Sulfate Injection
The main ingredient of this product is: Amikacin sulfate.
Name Description Content CAS NO. Registered Holders
Amikacin sulfate salt

Amikacin sulfate is an aminoglycoside antibiotic that has good effects on most Enterobacteriaceae, Pseudomonas aeruginosa and other Pseudomonas, Acinetobacter, Alcaligenes, etc. It also has good antibacterial effects on meningococci, gonococci, influenza bacilli, Yersinia, Campylobacter fetus, Mycobacterium tuberculosis and some Mycobacterium. Its antibacterial activity is slightly lower than that of gentamicin, but it is stable to the aminoglycoside inactivating enzymes produced by many intestinal Gram-negative bacilli. The mechanism of action is to act on the 30S subunit of the bacterial ribosome and inhibit bacterial protein synthesis. Combination with semi-synthetic penicillins or cephalosporins often achieves a synergistic antibacterial effect.

More

Amikacin sulfate is an aminoglycoside antibiotic that has good effects on most Enterobacteriaceae, Pseudomonas aeruginosa and other Pseudomonas, Acinetobacter, Alcaligenes, etc. It also has good antibacterial effects on meningococci, gonococci, influenza bacilli, Yersinia, Campylobacter fetus, Mycobacterium tuberculosis and some Mycobacterium. Its antibacterial activity is slightly lower than that of gentamicin, but it is stable to the aminoglycoside inactivating enzymes produced by many intestinal Gram-negative bacilli. The mechanism of action is to act on the 30S subunit of the bacterial ribosome and inhibit bacterial protein synthesis. Combination with semi-synthetic penicillins or cephalosporins often achieves a synergistic antibacterial effect.

149022-22-0 9
Estradiol Benzoate Injection
The main ingredient of this product is estradiol benzoate. Its chemical name is: 3-hydroxyestrone-1,3,5 (10)-triene-17beta;-ol-3-benzoate. Its structural formula is: Molecular formula: C25H28O3 Molecular weight: 376.50
Name Description Content CAS NO. Registered Holders
Estradiol benzoate

Estrogen drugs. They can cause endometrial hyperplasia, enhance uterine smooth muscle contraction, and promote breast development and hyperplasia. Large doses inhibit the release of prolactin, counteract the effects of androgens, and increase calcium deposition in bones.

More

Estrogen drugs. They can cause endometrial hyperplasia, enhance uterine smooth muscle contraction, and promote breast development and hyperplasia. Large doses inhibit the release of prolactin, counteract the effects of androgens, and increase calcium deposition in bones.

50-50-0 9
Estradiol Benzoate Injection
The main ingredient of this product is estradiol benzoate. Its chemical name is: 3-hydroxyestrone-1,3,5 (10)-triene-17beta;-ol-3-benzoate. Its structural formula is: Molecular formula: C25H28O3 Molecular weight: 376.50
Name Description Content CAS NO. Registered Holders
Estradiol benzoate

Estrogen drugs. They can cause endometrial hyperplasia, enhance uterine smooth muscle contraction, and promote breast development and hyperplasia. Large doses inhibit the release of prolactin, counteract the effects of androgens, and increase calcium deposition in bones.

More

Estrogen drugs. They can cause endometrial hyperplasia, enhance uterine smooth muscle contraction, and promote breast development and hyperplasia. Large doses inhibit the release of prolactin, counteract the effects of androgens, and increase calcium deposition in bones.

50-50-0 9
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.